Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

2012

4257 ARTíCULOS , VIENDO DEL 121 AL 135

PUBMED

Therapy in Huntington's disease: where are we?

Nance MA.

Curr Neurol Neurosci Rep. 2012 Aug;12(4):359-66. doi: 10.1007/s11910-012-0277-4. Review.

0

0

0

PUBMED

Randomized controlled trial of community-based dancing to modify disease progression in Parkinson disease.

Duncan RP, Earhart GM.

Neurorehabil Neural Repair. 2012 Feb;26(2):132-43. doi: 10.1177/1545968311421614.

0

0

0

PUBMED

Anhedonia in Parkinson's disease: an overview.

Loas G, Krystkowiak P, Godefroy O.

J Neuropsychiatry Clin Neurosci. 2012 Fall;24(4):444-51. doi: 10.1176/appi.neuropsych.11110332. Review.

0

0

0

PUBMED

Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease.

Rousseaux MW, Marcogliese PC, Qu D, Hewitt SJ, Seang S, Kim RH, Slack RS, Schlossmacher MG, Lagace DC, Mak TW, Park DS.

Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15918-23. Erratum in: Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11212.

0

0

0

PUBMED

Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study.

Winter AC, Schürks M, Glynn RJ, Buring JE, Gaziano JM, Berger K, Kurth T.

BMJ Open. 2012 Mar 23;2(2):e000866. doi: 10.1136/bmjopen-2012-000866.

0

0

0

PUBMED

Drugs for treating Parkinson disease.

Belavic J.

Nursing. 2012 Jul;42(7):69. doi: 10.1097/01.NURSE.0000415323.71630.60. No abstract available.

0

0

0

PUBMED

[Molecular mechanism of botlinum toxin therapy for spasticity].

Sakamoto T.

Rinsho Shinkeigaku. 2012;52(11):1270-1. Japanese.

0

0

0

PUBMED

Quality of life of a person with Parkinson's disease and the relationship between the time of evolution and the severity of the disease.

Navarro-Peternella FM, Marcon SS.

Rev Lat Am Enfermagem. 2012 Mar-Apr;20(2):384-91. English, Portuguese, Spanish.

0

0

0

PUBMED

The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis.

Baker D, Pryce G, Jackson SJ, Bolton C, Giovannoni G.

Mult Scler Relat Disord. 2012 Apr;1(2):64-75. doi: 10.1016/j.msard.2011.11.001. Review.

0

0

0

PUBMED

Botulinum toxin clinic-based epidemiologic survey of adults with primary dystonia in East china.

Wang L, Hu X, Liu C, Wu Y, Wang C, Wang Z, Chen J.

J Mov Disord. 2012 May;5(1):9-13. doi: 10.14802/jmd.12003.

0

0

0

PUBMED

Redefining Parkinson's disease research using induced pluripotent stem cells.

Pu J, Jiang H, Zhang B, Feng J.

Curr Neurol Neurosci Rep. 2012 Aug;12(4):392-8. doi: 10.1007/s11910-012-0288-1. Review.

0

0

0

PUBMED

A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease.

Pouclet H, Lebouvier T, Coron E, Des Varannes SB, Neunlist M, Derkinderen P.

Neurogastroenterol Motil. 2012 Apr;24(4):e202-5. doi: 10.1111/j.1365-2982.2012.01887.x.

0

0

0

PUBMED

[Laryngeal dystonia and asthma: diagnostic difficulty and treatment. Case report].

Mobio N, Boua N, Kouassi S, N'Gattia KV.

Rev Laryngol Otol Rhinol (Bord). 2012;133(3):165-7. French.

0

0

0

PUBMED

A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers.

McNeill A, Duran R, Hughes DA, Mehta A, Schapira AH.

J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):853-4. doi: 10.1136/jnnp-2012-302402. No abstract available.

0

0

0

PUBMED

Duodenal levodopa/carbidopa infusion therapy in patients with advanced Parkinson's disease leads to improvement in caregivers' stress and burden.

Santos-García D, Añón MJ, Fuster-Sanjurjo L, de la Fuente-Fernández R.

Eur J Neurol. 2012 Sep;19(9):1261-5. doi: 10.1111/j.1468-1331.2011.03630.x.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy